S&P 500: 662.29 -0.6% NASDAQ 100: 593.72 -0.6% Dow Jones: 466.41 -0.2%

Teva Pharmaceutical Industries Limited

TEVA Healthcare
$28.57 $-0.73 (-2.49%)
Market Cap: $32.85 B
Gurus Holding
11
Popularity Rank
#334
% of Shares Held
2.34%
Net Activity (Q4 2025)
-$523.71 M

Guru Ownership Trend

Guru Analysis for Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Industries Limited (TEVA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 11 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $779.63 M.

Top institutional holders include Larry Robbins and Stanley Druckenmiller.

Notably, Larry Robbins has expressed high conviction in this stock, allocating 10.62% of their equity portfolio to it.

Institutional sentiment is currently Bearish. This is evidenced by a $523.71 M net outflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Stanley Druckenmiller reduced exposure by 64.6%.

Key Holders

Top 5 by Value

$521.84 M
$95.46 M
$23.54 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$2.09 M
Total Buy Value
New Buys 2
Additions 2
-$525.81 M
Total Sell Value
Reductions 7
Sold Out 3

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
10
Net Buyers
4

FAQs for Teva Pharmaceutical Industries Limited (TEVA)

Major holders include Larry Robbins ($521.84 M), Stanley Druckenmiller ($183.36 M), David Einhorn ($95.46 M). According to the latest reported data, 11 tracked investment managers collectively hold approximately 27.29 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $523.71 M, with 4 managers increasing positions and 10 managers reducing holdings.

During the most recent reporting period, 7 managers trimmed their positions, while 3 fully exited TEVA. The total reported sell value was $525.81 M.

Yes, 2 managers opened new positions in TEVA, and 2 increased their existing holdings. The total reported buy value was $2.09 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
10.62% Add 0.2% 16,720,209 $521.84 M Q4 2025
4.08% Reduce -64.6% 5,874,870 $183.36 M Q4 2025
3.35% Reduce -19.1% 3,058,734 $95.46 M Q4 2025
0.09% Reduce -12.8% 754,093 $23.54 M Q4 2025
0.03% Reduce -23.1% 500,000 $15.6 M Q4 2025
0.02% Reduce -11.5% 105,131 $3.28 M Q4 2025
0.05% Reduce -36.8% 104,333 $3.26 M Q4 2025
0.03% Reduce -2.2% 87,200 $2.72 M Q4 2025
0.00% Add 56.0% 68,937 $2.15 M Q4 2025
0.00% New Buy 14,782 $461,346 Q4 2025
0.00% New Buy 44 $1,379 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form